| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |